Dabur India Limited — FDA Class II (D-0629-2026)

Dabur India Limited is recalling 1,102 tubes of a drug due to CGMP (Current Good Manufacturing Practice) deviations. The recall is classified as a safety issue. The recall affects products distributed in the U.S.

• •Dabur India Limited is recalling 1,102 tubes of a drug.
• •The recall is due to CGMP deviations.
• •This is classified as a Class II recall.
• •Consumers should check their medicine cabinets for the affected product.
• •Recalls like this typically weigh on the company's reputation.

Consumers who purchased this drug should check for the recalled 1,102 tubes. The recall is due to manufacturing deficiencies.